1114 CRtMtN.\LJL::.TICI .\ND 1\tll.\\"tUR The lack of underlying frame\\ orb for guiding drug court re~earch mean~ that there i~ limited information on the procc~se~ or critical componcnb of drug courb that affect their outcomes (Bclenko, 2002a (Bclenko, . 2002b Longshore et al., 200 I; Marlowe et al., 2003) , including effects on specific type:::. of individuals \\'ith particular drug and other social or health problems (Joe, Simp:::.on, & Brt,omc, 199S; Simpson ct al., 1997; Sung, Bclenko, Fcng, & Tabachnick. 200-l) . The match between the nature and sc\crity of drug problems and the type and inten:::.ity of the treatment delivered greatly affi::cb treatment impacts (Bclcnko & Peugh, 2005; Mclellan & McKay, 2002; Mcc-lce, Shulman. Fishman. Ciastfricnd, & Griffith, 2001) . For criminal justice populations in particulat~ theory and research on the risk-nceds-rcsponsivity principle indicate that failure to appropriately match the intensity of treatment to le\·cl of risk and treatment need of the client can lead to poor outcome~ (Andrews & Bonta, 2003; tvlarlowc, 2003; Taxman & Thanncr. 2006) .
These issues arc particularly important because, similar to other criminal-justice and community-ba:::.cd behavioral health interventions, drug court:::. :::.crvc relatively small segments of the population with drug problems, perhaps 5% or lc::.~ (Belenko, 2002b; Bhati & Roman. 20 I 0) . Considering that 70% to f\0°~, of all offenders arc estimated to have drug usc disorders (Bclenko & Peugh. 199R; Bhati & Roman. 20 I 0) , it is dear that drug courb arc serving a very small percentage of potential client:::. .
CANDIDATE SELECTION FOR DIHIG COURTS
The types of persons admitted may intluence the performance of drug courts more than drug courts influence the people selected. r,, o propo~cd conceptual frameworks ti.)r guiding drug court research ~upport the importance of Ull(kr~tanding the process of selecting and recruiting candidates into drug courb. Ba~cd on a rc\ ie\\ of 14 adult drug court:::.. Longshore ct al. (200 I) developed a fi, c-dimcnsion fn1mc" ork: levcr:~gc, popubtion severity, intensity, predictnbility. and rehabilitation emphasis. Leverage refers to the nature of consequences faced by participants for program failure, such as CL)Utt-i mposcd sanction~ or imposition of a punitive sentence. Population SC\ crity refers to characteristics of the target population related to drug usc severity. criminal histOt). and risk level. Intensity refers to program requirements (e.g .. urine testing, court appearances, trcatmem). Rehabilitation emphasis is measured against other functions. such a::. case processing and punishment. Cioldkamp ct al. (200 I) specified contcxtunl characteristics that may aftect drug courts. proposing a set of internal and cxtcmal dimcn~ions as a ll-.:mJcwork for identi(ving key cnusal factors that predict cftectivcness. These include the types of targeted drug and ctime problems. target population, drug court model (diversion or postconviction). screening and assessment process, treatment structure or Cll!Jtcnt, sanction ami rc\\'ard structure, and extent of system ::.upport. Both of these models :::.uggcst the importance of understanding the difterenccs bet\\ ccn target populations and tho:::.c that enroll in d111g courts, and their suitability ti.)r long-term treatment.
Selection effects ma) limit the ''penetration" of drug courb and similar intervention::. into the target population. In drug court and treatment eli' er:::.ion program~. it i~ t) pi cal for only about one third of eligible offender~ to be admitted to the program~. "ith one third rejected during the recruitment proce::.!> and one third rcfu~ing to participate (Belcnko. llllp.tl'-'J U.,d~<=pUU.'-UIIU '-UIIlCIIU _10/ 1£./ l.t..t..t..JUJl.pUl 5 of23 l.kknk0 ~~ "' \l"Rll NINe 1.\ \IIJ ADilll~'-ION IN1U DRUG COURTS 1125 200.2b; Lang & Bdcnko. 2000) . More broadly, patient::. ~clf-~clcct into voluntary treatment programs a:-well a::. clinical research. including randomized trinls, and thus arc not necessarily rcprescntntivc of the brondcr tnrgct population (Tuch.cr & Roth, 2006; WoltT. 2000) . Eligible candidates typicnlly ~clf-::.clcct to participate in mndomizcd clinicnl trials. resulting in poor cxtcmal vnlidity and lo\\ gcncraliLability (Brown ct al., .2009; Grimshaw & Eccles, 2004; Schulz. Chalmcr::.. llayc::., & Altman. 1995; Tucker & Roth, .2006 ). In part this may explain why it can be difticult to replicate ::.ignificant effects\\ hen interventions arc brought to scale or implemented in difTcrcnt ::.itcs umkr lc::.~ rigorou::. experimental controls.
The reasons for this apparent lack of penetration into the potential target population for drug courts (as with other inten cntion::.) arc not clear. A~\\ ith other problem-solving courb, the process of recruiting, screening. nnd admitting offenders into drug courts may be complex nnd cncompnss many stnkcholdcrs from eli tTcrcnt ngcncic::. nnd with different levels of expertise nnd perspecti\e: :. (\Volt[ Fabrikant. & Bclenko, 2010) . For example, although formal drug court eligibility criteria may limit achni::.::-.ion to tho::.c with felony drug possession charges, many other criteria (both formal, ::.uch a::. nature of their criminal histo1y. and inti.1rmal criteria such a:-"suitability" for treatment) may be considered. Potential clients may be referred to the drug court fi·om a number of different ::.ourccs (e.g., a prosecutor, dcfcn::.c attorney. nunily member, treatment prO\ idc1~ ::.entcncing judge. or jail personnel_).
Candidates may be ~crccncd formally by the drug court team or a case coordinator with clinical ::.ubstancc nbu::.c training, wi til or without input fi·om drug treat mcnt staff. Scrccncr::-. may or may not 11<1\ c fi.1rmal training in clinical diagno::.c::. of drug abuse disorders. and staff may ha\c different incentives for accepting or rejecting potential recruits, further incrcnsing potential ::.clecti on bias (Redlich, Hoover, S ummcr::.. & S tcadman, 20 I 0). For example. pm::.ccutor::. ha\ c a11 incentive to admit lo\\ -ri::.k dicnb or tho~c with weak criminal case C\ idcncc. Drug court ~tafT may have an inccnti\ c to accept clients not needing long-term treatment to incrca::.c the cascload and justif~v funding. Eligibility determination may be fi.1rmalizcd in a protocol or be more inli.1Imal and idio::.yncratic. Even if clients nrc found eligible. is::.ucs of treatability, motivation, and ::-.upport from the defense attorney may independently aftect client recruitment and selection.
Many drug courts arc voluntary in that an eligible oflenckr can choose to participnte or not based on motivation to address his or her substance nbusc problem, ach icc of dcfclbC attorney. or weighing the benefits and disadvantages of drug court participation. For the low-level or first-time offenders that arc targeted by many drug court~ {c::-.pcciall)· prcplea diversion programs), drug court pnrticipation may require more ::.upcn ision and more stringent requirement::. than standard sentences such as probation ora !>hort jail tem1 (1-loiTman, .2002; Nolan, 200 I) . Thus, drug courts that target or admit low-ri::.h. offender::. ma) ··widen" or ''tighten" the net of social control and create disincentives for offender!> to 'oluntccr.
Taking all this into account. it may be that the positive result::. reported in drug court evaluations nrc affected by targeting and admission procedures (e.g., admitting participant::. without drug abuse disorders or with low risk) or by selection bin:-, rather than the program itscl f( Luskin. 200 I; \Vol ff ct al .. 20 I 0; \Vol tT & Pogorzelski . .2005 ). It i::. surprising that the process of recruiting. screening. and admitting clients, the nppropriatcnc!>::. of the tnrgct populations, and the extent to which drug courts penetrate the planned tnrgct population hm c rarely been considered in drug court rc!>earch (Goldkamp . .20 10; Goldkamp ct al., 200 I ). As a consequence. it is eli rticult to interpret the gcncralizabil ity of the C\· ide nee ba::.c cited above, to provide guidance for effectively replicating and expanding drug courb, or I Among the courts with ;:1\ ailable inti..mnation, 9S (45°;)) met the tin.t three eligibilit) criteria. For the tourrh criterion, these 98 \\ere ranked by ca::.cload ::. izc ranging ti·om 9 to 1,000 participants (M = 137, SD = 263). We divided the range into quartiles and first selected courts in the second and third quartiles (33 to 130), excluding court:. on the taib of the cascload size distribution. To ensure regional rcprcscntati\ cnc::.::., three of the selected courts had a program size oubide the second and third quartile::. but ''ere located in a targeted region of the United State~. All six courts selected agreed to participate in the stud). They served 60 to 400 client::, per year in geographic area::. with populations bct\\CCn I 00,000 to over I million in the Northca::.t, Southea~t, Mid'' e~t. Soutll\\ e::.t, or Pacitic Northwest. Based on the number of adult arrests t\.)r any t)pC of drug otTcn::.e, the courb serve a range of0.1°'n to 5.6%, of the potentially eligible population. This is a rough estimate (although it is consi~tent with pre\·iou::.ly published penetration e::. timatcs) becau::.e data were not available on the proportion of paper-eligible offender::. '' i th drug abu~c problem~. or the numbers of arre::. ted or com ictcd o ffendcr~ meeting all \\ rittcn cligibi lit) criteria. Our sample included both pre plea diversion and po::-tplca mock!::-(three court::. had t\\ o trncb), and in only one drug court was there no imohcmcnt of the pro::.ccutor or public defender. Two of the six program::. prO\ idee! treatment in the drug court, and the others contracted to community-based prO\ idcrs (::-ec Table I The respondent sample included key ~taff atliliatcd '' i th each drug court, such as j udgc::., prosecutors, defense attorney~, probation, and program stafC in addition to staff ti·om organizations providing cl icnt ~en icc~. Sno\\ ball ::-amp I ing ''a::-used to identi t)' respondent~. Initially, key informanb fi.lr each court "ere iclentiticcl through discussions with a court liaison and a review of rclc\ ant court materiab. From thc::-c initial interviews, other key informants were identified. A totalufi\(i people were approached ti.1r an imervicw, of,, hich S4 (9S%.) agreed: written informed con~cnt ''as obtained, and all study protocol::-were approved by the Rutgcr~ and Temple Uni\er~ity in::-titutional review boards. The total sample included 9 judge::-; 10 pro::.ccutor~: 6 defense attorneys; 9 drug court manager~, coordinator::., or ~upcn i~ot-s; II other drug court staff: 14 service pro\ idcrs: 7 probation, Two authors spent I week at each site between March and July 2009 conducting interviews ami obscn ing court sessions and staff meetings. Scmistmctured interviews ''ere conducted in pcr::..on, audio-recorded, transcribed, and analyzed using ATLAS.ti software. Court sessions and ::..tafT meetings were not rccordec~ but extensive field notes were taken. A preliminary codebook \\as created on key themes that emerged during the interviews. Two researchers independently coded all of the transcripts. During the coding process, the reviewers discus~cd and came to an agreement on all coded passages and redefined, deleted, added, and me1gcd codes until a final eodcbook was generated. One researcher then conduct.ed a ::,ceoml-and third-stage analysis of the portions of the data pertaining to the client identification, selection, and recruitment process. In addition to the field data, written background material was obtained ti·om each court and used in the analysis. Thi::. information included initial court pro::.pcctu::. or grant application, historical document::, describing a::.pccb of the court and ib modification, quarterly and annual report::, and court evaluation::, (proce::,::. and impact), and document::. related to intixmcd consent, \\·ai\ cr::,, and cligibilit) determination.
The general proce::,::. ti·om initial eligibility determination to admission into the drug court has four main components. depicted in the t\.)llowing ::.chcmatic.
Paper eligibility ---7 Screening ---7 Clinical assessment ---7 Admission PotJa cligihilily. Drug courts generally ha\ c formal eligibility criteria that arc rcvie\\ cd during the initial case screening. These criteria u::,ually focus on legal i::,suc~ ::..uch as cmrcnt criminal charge and criminal history. Most drug Cl\Urb, c::,pccially tho::.c that receive federal funding. do not accept participants that ha\ e been com icted of a \ iolcnt crime, and most do not accept those with a current drug-selling charge(\\ ith some exception::, noted bclo\\ ).
Screening. During the initial or earlier ::,tagcs of the admis::.ion proec~::.., brief screening is conducted to provide initial information about the candidat..::'~ drug lbC ::..latus. This ma) simply relate to the euJTent charge (i.e., drug po::..::.c::,: : . . ion), a re\ ic\\ of the candidate\ criminal history (prior drug possession com iction::,), or an inten iC\\ '' ith the candidate. Other objective or formal indicators of a drug problem may al so be noted.
Clinical as.1·essmen1.
Once there is an initial indication of a drug problem, some courb will conduct a more fonnal assessment using a clinical a::.::,e::..::..ment tool : : . .uch as the Addiction Severity Index (ivlclcllan et nl., 1992) . A drug treatment coun::.clor or other trained staff may conduct an a::..::,essmcnt to determine the nature and ::,c\ erit) of the per~on's drug problem. Information may also be gathered on the candidate'::. moti\ ation tor treatment and other social or health problem::. (e.g., mental health ~latus). Screening and assessment for drug abuse disorder~ may occur at multiple poinb in the admi::.~ion process. The diagno::.tic criteria for substance abuse and need for treatment vary by drug court.
Admission.
The final phase is fonnal admission to the drug court. In some courts the candidate is inten icwed by the drug court judge. Some drug courts offer an orientation period of about 30 da)::. when the candidate attends drug court hearings and treatment sc::.-sions. After that period the drug court staff and candidate both decide whether to continue in the drug court.
For each o fthc abO\ c components, and at each temporal stage of the admissions proccs::., a ··gatckcepcr''lm::. primal)' responsibility for case review and decision making. Cicncrall). this is either a pro::.ccuting attorney or a drug court team member. Both formal (paper or legal eligibility) and informal (subjccti,•c) criteria arc used in different courts at different times, although most drug courts usc a combination of fi.)["[nal and intl.1I'l1lal criteria. Informal eligibility criteria arc of course more subjective but may directly influence admission to the drug court.
Our data indicate two basic models fl.1r drug court scrccniwr' displayed in Figures I and 2 . Each model has three key stages, through which a case moves from initial idcmilication llr recruitment of potential clients, to more intensive and complex screening and a~~c::.~ment processes, to final eligibility dctcnnination and admission into the drug court. At each stage, drug courts vary regarding the key gatckccpcr(s) or decision maker!>, the type::. of inll.1rmation reviewed to assist decision making, the amount of discretion and infl.1rnml dccbion making invol vccl, and the level of complexity of the process. Stage I im oh C!> the ini rial paper cligibil ity cktcrmination and ::.crccning. generally based on formal objccti\c criteria related to legal criteria (only two courb, I and 5, also conduct substance abu~e !>Crccning at this point). At Stage 2, additional ~crccning and asscssmem arc conducted, generally by drug court staff~ to assess the nature of the candidate's drug problem and suitability 11.1l " treatment and identify other aspects of the case and the indi' idual. The final stage, Stage 3, im olvcs review by the drug court judge, participant con::.cnt, and an orientation or opt-out period ll.1r three of the drug courts.
The two models differ primarily by the key gatekeeper at the initial eligibility !>Crccning stage, as shown in the ccntr·al node of Stage I. In the first model ( Figure I ), the dbtrict attorney (DA) is the gatekeeper for the initial fl.1I'l1lal paper eligibility determination and b the key decision maker ll.1r initial acceptance. Although cases may be referred to the DA fi·om eli fterent sources, an individual in that office conducts initial screening of the ca~c based on formal eligibility criteria that have typically been negotiated by the drug court stafT and other key criminal justice system personnel. In the second model (F igu rc 2 ), drug court team members arc primary gatekeepers ll.1r initial eligibility screening, rccci\ ing referrals from a number of sources including DAs. 
: During Stage I, ·'initilll eligibility screening,''" case comes to the atlcntion of the pcr::.on or persons responsible fi.1r initially identifying a potcntinl drug court case. This gencrall) occurs in one of two \\ays: (a) Staff from other criminlll justice agencies refer a C<1:.-C to the initial "gatekeeper," ei tiler the prosecutor or a member of the drug court team, or (b) certain types of cases arc routinely screened by the initial gatekeeper. For example, in Court:.-2 llndJ and the diversion tracks in Coutts 4 and 6, \In assistant DA routinely reviews aline\\ felony drug possession cases, primarily by examining the criminal history to screen out persons with extensive or violent criminal histories (diversion track cases generally :,hould not have any ptior com ictions). Referrals fi·om other agencies arc more comn1on in drug courts with postconviction or probation tracks and can come from the prosecutor, dcfctbC attorney, sentencing judge, or a probation ofticcr (Courts 4 and 6).
Stage I eligibility criteria usually include the criminal charge and criminal history (all courts in our sample). There were clear differences in the eligibility criteria lind screening process. Diversion trncb generally target first-time low-level offenders (mainly drug po:,-scssi on felony charges, though Courts I, 4, and 6 will make exceptions on a casc-by-ca::.c basis t~1r charges that arc determined to be drug related) and do not allow drug sellers (exceptions arc Courts 2 and 3). DAs arc usually the primary gatekeepers for di\'cr::.ion cases. For the post plea tracks, cligibil ity criteria arc broader. Sometimes the charge mu::.t be a drug chatgc, though Sl1mc courts will accept other charges if the person's criminal activity is thought to rctlcet a drug problem. Usually a postplca candidate will not be accepted if he or she hn::. prior \'iolent crimes (although Court:.-I, 4, 5, and 6 allow prior \'iolcnt crimes on n case-by-case basis). For most drug courts, the criminal charge must be a drug offense. generally drug possession. All courts usc other fl)tmal or informal cxclu~ion criteria for which inf~mnation is gathered at Stage:.-I and 2.
During Stage I. infi.11111al eligibility criteria abo arc considered on a ca:.-c-by-ca::.c basi:.-in some drug courts. For example, Co uti I require::. potential participant~ to ha\ e reliable tran:.--portation to the drug court and to ~ho\\ a dc::.irc to get treatment. In Court 3, the DA might consult with the clctensc attorney to ::.cc if mitigating evidence allows consideration of a k)w-levcl seller, and in Court 4 the DA may :.-pea h.\\ ith the dcfcn:.-c attorney to determine if the participant has a stable socioeconomic ::.ituation that might mitigate lo\\ard admi~:,ion.
Additional initial screening criteria other than the current criminal charge and criminal history arc sometimes u:.-cd: Drug cuurt ~tafT in Courts I and 5 abo conduct a clinical assessment at the tirst stage to determine if the otTcndcr ha::. a ::.ub:.-tancc abuse problem. Those withl1Ut any indication of a problem arc :.-crccncd out at this carl) point. Variou~ other restrictions were noted by eli fie rent courts, such as no gung member!>, too much rc:.--titution owed, multiple prior probation' iolation~. or being a:.-sc~:.-cd a~ too lo" ri~k (f~)r a court that targets "higher-risk" participants).
At Stage 2 (''eligibility assc:.-:.-mcnt'"), a more in-depth and clinically driH:n a::.::.c:.-:.-mcnt determines the participant's lc\cl and type of::.ub:.-tancc nbu::.c problem, mothation to par-IILLt-Jollt. ..jUol:lat;t...t-JUU.t...VIIJit...UIILt...IIUJU/1£..11£..£..£...1UI1.pU1 lkknk,, ~~ al ~CREENIN<:J ANIJ .\Dl\11~'-10\l INTU DRU<.r COURT'-1~33 In the final stage, Stage 3 ("'judicial and client approval"), the client meets the judge, receives an orientation to the drup; court, and may be otfcrcd a .. trial" period in which hc...Q.r shb attends drug court and treatment for a short pctiod (usually 30 c '· is a good ''tit." At the cnc o t mt opt-out period, the client mav decide not to artici 1atc in t 1c c rug court and return to regular criminal case 1rocessing or receive the predetermined sentence). or the j uc gc may not allow the person to be admitted into the dru T court bccau::.c of a perceived lack o appropnatcncss for the pro Tt.ll1l . T esc informal and rather subjecti\ c cntcria arc a not 1cr source o vanatton anc selection effects in the process of admitting drug court clients. Half of our sample drug courts (Courts I. 4, and 6) offered an orientation or o 1t-out pcrioci of about 30 davs. Data were not available from these courts as to what percentage of potcntta c icnts is not admitted to the drug court fhllowing the opt-out period.
In most of our sample courts, the judge initially follows the rccommcmbtion ofthc drug court team and accept::. their recommended participants into the program. Only in Court 6 doc::. the j uclgc sometimes exercise veto power over the potential candidates, and in the Court I po::.tplea track the original sentencing judge must agree to allow the offender to participate in the drug court. TilliS, although research and thcor~ on the judge's rl1le in drug court::. ::.ug:gc::.t that they arc the ptimary decision makers (Marlowe & Kirby, 1999; Satel, 199F ) . in the admission process the judges in our sample drug courts deferred to other staff and drug court team members ft)(' key screening and admis::.ion decisions. DISCliSSION b::.uc::. of ::.election bias and penetration into the target population in drug courts and other problem-::.ol' ing courts such as mental health courts ha\ c been raised by critics as a possible explanation fhr their putative treatment and criminal justice outcomes (Bclcnko, 2002a : Bclcnko, \Voltf, & Holland, 2009 . This bsuc reflects more general concems about target population penetration in behavioral health services. Our study involved a qualitati\ e analysis of the selection procedures and processes of a national sample of drug court::.,\\ ith the goal of furthering our understanding of the selection and admission procc::.s for idcnti~ying, screening, and admitting clients into these programs.
We found both commonalities and differences across different courts. First, two distinct models emerged that eli tTcred mainly by the gatekeeper conducting initial ft11'11lal screening: the DA or the drug court team. TheDA model generally operated for drug courts that were based on a pre plea eli\ crsion mode1 or fi.1r the diversion track::. in drug courts with both diversion and postplca tracks. For dntg courts with postplca tracks, the ~!rn~r court team ll)Odel dominated.J-Iowcvcr, there were exceptions to this: Court I has both prcplca and postplca trnck::. but tit the drug-court team gatekeeper model. Courts 2 and 3 both fit the DA gatekeeper model, yet one i::. a po::.tplca and the other a preplea diversion drug court. Second, all drug court::. had three di::.tinct stage:, in the ::.crccning and admi::.sion procc::.::., operating in the ::.a me ::.cqucnce. An i!2!_ tial cl igibility ::.crcening \\as based on.J11rmal criteria typically related to criminal charge and cmmnal his torY. The second stage (c!igibilitv a::.::.c::.::.mcnt) incorporated clinical assc::.::.mcnt::. n::. ''ell a::. other re\ icw and screening by ililfliJiiS th tfg court ::.takcholclcrs. The focus here \\·a::. on C\ iclcncc for ::.ubstancc abu::.c di::.-orclcr., and treatment needs, as well as other behavioral health and social i::.::.ucs. Criteria for defining the drug dbordcr and treatment need varied widely among the courts but were not typical!) ba::.cd on formal drug abuse or dependence diagnoses. More informal and subjccti\ c critelia ''ere u::.ed to determine suitability or readiness tor treatment.
The final ::,tagc (judicial and client a mwal) involved a decision by the drug court judge. client con:-cnt o participate, and, t~r half the drup; courb. an orientation or opt-out trial pcnocl. In the oft he six drug courts the judge follows the recommendation of the drug court team, and although the judge in Court 6 maintains veto power, that judge usually abo foliO\\:> the team'::. rccommcndntion. tvlost judges generally relied on the decisions made by the drug court team. although an orientation period in three of the courts allowed a mutual "tc::.t" of the client's suitability tl.w drug court. In making their final decision to participate (and incorporating legal advice from their attomcy), clients may weigh the bcnclit:, and di:,achantagcs of participation relative to the likely outcomes ofthcircriminal case unckr standard criminal court processing. Intrinsic motivation tl.1r treatment and selfawareness of a drug abuse problem arc other t~tctor:> likely to be considered by the client. Although none of our ::.ample drug courts had dnta on the proportion of eligible clients who choose not to participate in drug court, other drug court rcsenrch suggests thnt n substantial percentage (perhaps one third) decide not to enroll (Bclenko, 2002b) . Such a decision may be rational and in the be::.t interests of the client. Without additional research on the reason::. tl.1r nonconscnt and its impact on selection bias, we arc lcti to speculate.
That said, however, the cftccts on drug court outcomes might eli ftcr depending on whether clients refusing participation would have been suitnblc for the drug court and. thus, bcnclitcd from trcntment. In contrast, diversion-eligible offenders with limited criminal histories and low ::.evcrity of drug problems may accurately pcn.:cive that they do not need the long-term treatment and intensive supervision of the drug court and would benctit by proceeding through standard adjudication. where thci r cases might be dismissed or they might be sentenced to minimnl supervision under probation. Treating low-risk offenders in intensive program::. such a::. drug court:, negatively affects drug court outcome::. a::. well as their cost-ct1ccti vcncss (Fest ingcr ct al., 2002; l'vlarlowc. 2003; Thanncr & Tax man, 2003; vv·olff, 2002) and' iolatc~ principles of risk-ncccb-rcsponsivity in criminal ju::.ticc programming (Andrews & Bonta, 2003; !Vlarlowc. 2003; Taxman & Thanner, 2006) .
The drug court selection procc::.::. thus incorporates multiple stages, criteria, and ::.tafT f1·om eli ffcrcnt ngencics. Admi::.::.ion i::. based on decision::. mack by multiple stakeholders at eli ftc rent points in the proce~~-TheDA is a primary gatekeeper whose npproval i::. &rcnerally needed (with the exception of one court) at either Stage I or Stage 2. The central role of the DA. with veto power either in the beginning of the process in Stage I or later on, is con::.btcnt with the criminal court procc~:-in general. \\here control o\cr initial charging. C\ iclenthll) review, and plea bargaining means that prosecutors arc generally the primary e,ratckecpcr::. and decision makers in the rc::.olution of criminal ca::.e~ (Aibonctti, 19R7; Ball, 2006; \Vilmot & Spohn, 2004) . At all :,tage::., the client and his or her clclcnsc attorney mu::.t agree to participate and weigh the benctit::. and con:-cqucncc::. of drug court pa1ticipation. Multiple members of the drug court team may be im ol\ eel and decide '' hcther a person is suitable tl.1r the progmm based on tl.11"111al and informal criteria. The drug court judge cnn rcfu:,c admission to the drug court or decide during an orientation pha::.c that a client is not suitable.
It is not kno\\ n hO\\ typica I it b for j udgc~ to O\ crrulc a drug team·~ rccommcnda tion to admit a client, but gi\cn the power that criminal court judge!"-< cxcrci ::.c in their courtroom::., it is not unrea::.onable to ::.peculate that tlli::. occur::. in other drug court~ a~ well. In the postplea drug courts, the original sentencing judge or probation orticcr must decide to refer a case to the drug court and approve the person's participation. Finally, although courts may have specific eligibility requirements, occasional exceptions are made. Some admission decisions arc made on a case-by-case basis and arc based on more informal criteria.
LL\IIT:\TtOl\S Scveml I imitation::. in our study should be noted. AI though our ::.ample was rcpre::.cntative of different region::. and cascloads, it included only six court~. It i pos::.iblc that larger samples of drug courts \\Ould have uncovered different models of::.crccning and admb~ion or demonstrated more or less variability in the process. Furthermore, \\C excluded from our sampling n·amc drug courts with very low or vcty high caseload::., ~o our finding::. ma y not apply to such program::.. However, our sample was selected to broadly represent the siLc, maturity, and geographic location of modal types of drug courts and for the purpose of understanding their selection and admission processes. Our goal was less to quantify the representativeness of each type of selection process than to describe general patterns and variations in the process.
Second, quantitative data on the screening and admission process were not available. Thus, the extent to which the drug court admission process contributes to their low penetration rate is not known at this time. Future work should develop tools for monitoring and analyzing this process. Finally, it may be that the screening and admission process differ::. by offender characteristics such as gender, racc/ethnicity, or socioeconomic status. Consideration of these factors'' as beyond the scope of this study but is worthy of future research.
CCli'I<'I.liSJO:\S :\i'IJ> Fl!TUR~. DtnE<"TIO:\S This qualitative study ofsix representative drug courts has identified a multi::.tagc, complex process for screening and admitting clients that involves a number of key dcei~ion poinb, gatekeepers, formal and inti.mnal admission criteria, and opportunitic~ ti.1r eligible participant~ to decline admission. Gi\ en the complexity of this process, it is not ~urprbing that drug court::. admit only a relatively small proportion of potentially eligible offender!>. Our finding:, ::.uggc~t that there is enough variation in the selection processes and opportunitic::. for modi f)•ing pol ieies and procedures to suggest the importance of developing method~ and toob to mca~urc and document drug court screening and admission proccss\..'S. Thc~c data would be important li.1r documenting and controlling tor selection effects on outcome::. in drug court evaluation~. The selection and admission processes could explain the variable effect ::.izes found in drug court evaluations; they may be driven by the variation in client ::.amplcs, rather than the drug court. This hypothesis cannot be tested without more stancbrdizcd method~ for comparing those admitted into the coutt to those not admitted, and testing the potential of drug courts to penetrate further into their target population of offenders with drug abu::.c di::.ordcr::..
Our general model ::.uggcsts that the types of client:, admitted into the drug court arc shaped by formal and inti.m11al selection criteria a::. well a::. by the local treatment ::.y::.tcm. The challenge is to de\ clop a tracking in::.trumcnt that can capture the\ ariation in meaningful and measurcnblc \\ay::.. It will be rdati\cly ::.tmightf\_11"\\ard to document :,crecning decision~ lkknk ,, ~~ al ;,c Rll Nll'Ci A '-:D .\Di\lh"ION INTO DRUG COURTS 11-l I based on formal cligibilit) or screening criteria. ~uch a:, criminal charges. criminal histor), and assessment of a drug dbordcr bn::.cd on clinical!) 'a lid tools. Measuring the cftects of more informal criteria based on :,ubjectivc j udgmcnt:, and preferences ''ill be more eli fficult. These challenge:, nrc ::.tll"111ountablc. however, and important for undet-standing the impacts of selection cftecb, '' hich in tum will improve our understanding of the cxi::>ting drug court evidence btbc, the potential for increasing pcncl!~tion into the target population. and the cfTcctivc componcnb of drug courts.
The posi tivc evidence from drug court research is often interpreted to ::,uggc:,t that if\\ c took any mndom oflendcr \\ ith a ::,ub:,tancc abuse problem and a range of com iction:, and assigned him or her to a drug court, the court would produce outcome::. in accordance\\ ith the evidence. This expectation. ho'' ever. is most valid if tho::,c participating in drug courts and drug court research arc reprc::.cntati\ c of the broader group of offender::. with sub:,tancc abuse problems. In drug treatment and other behavioml health C\ aluation:,, program effects arc highly contingent on the chamctcri::,tics of the otlendcr:, admitted to the program and the appropriateness of the ::.en-ice::, they receive (Bclcnko & Peugh, 2005; Marlowe. 2003; IVlclellan & McKay, 2002) . Drug court evaluations often lea\ c unexplored the extent to \\ hich the courts arc targeting appropriate populations, penetrating the target population in :,utl1cient IHlmber::,. and providing equal accc::.s to the intcncntion. To answer the question of "for whom" a program works, and what treatment sen ices arc needed to maximize po:,itivc outcome:,, it i:, important to undcr:,tand and document the process of selecting participants for I he programs. This type of e\ ide nee is central to the effectiveness 0 f thc::,c programs. their impacts on :,ubstancc abuse and crime, and the ability of drug courts to expand their client ba:,c and cftectivcly and ctlicicntly reduce drug abuse and drug-related crime.
